New Trial Seeks Diabetes Cure

Researchers at the University of Alabama at Birmingham (UAB) are conducting a double-blind human clinical trial in the hopes of finding a cure for diabetes.

The focus of the trial is on the high blood pressure medication Verapamil, which was found to reverse diabetes in mice. The UAB trial aims to see if the same results will hold true for humans.

“We really need volunteers,” Fernando Ovalle, MD, the director of UAB’s Comprehensive Diabetes Clinic and the Co-Principal Investigator of the study, told local news station WIAT. “We really need to know whether what has been found in the laboratory actually applies to humans.”

Read complete story.

You may also like

  • Circulating microRNAs Likely as Effective as A1C for Predicting Type 2 Diabetes in Youth

    Measuring the circulating abundance of microRNAs is likely as effective as measuring the level of sugar in the blood for determining how a young person with the condition will fare, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Jeanie Tryggestad, MD, an associate professor of pediatrics…

  • Two Medication Classes Reduced Cardiovascular and Liver Events in People with Type 2 Diabetes

    GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data presented at ENDO 2024. Researchers reviewed Medicare data documented from 2013 to 2020 and a large U.S. health insurance database from 2013 to 2022. They performed…